Concepedia

Jessica Kalra

JK

Statistics

Publications

11

Citations

467

H-Index

11

Active since

2003

Affiliations

BC Cancer Agency(Current)

University of British Columbia

Centre for Drug Research and Development

Institute for Research in Immunology and Cancer

Western University

Jessica Kalra is an author at BC Cancer Agency specializing in medicine, tumor biology, and radiation oncology.

ORCID

Top concepts

Publications per year

2003–2017

11

Publications

11

QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatment outcomes in an orthotopic breast cancer model

Jessica Kalra, Corinna Warburton, Karen Fang et al. · Breast Cancer Research · 2009 · 73 citations · Full text

5′-AMP-activated Protein Kinase (AMPK) Supports the Growth of Aggressive Experimental Human Breast Cancer Tumors

Keith R. Laderoute, Joy M. Calaoagan, Wan‐Ru Chao et al. · Journal of Biological Chemistry · 2014 · 70 citations · Full text

Suppression of VEGF secretion and changes in glioblastoma multiforme microenvironment by inhibition of Integrin-linked kinase (ILK)

Lincoln Edwards, Janet Woo, Lynsey A. Huxham et al. · Molecular Cancer Therapeutics · 2008 · 62 citations

Cx26 inhibits breast MDA-MB-435 cell tumorigenic properties by a gap junctional intercellular communication-independent mechanism

Jessica Kalra, Qing Shao, Hong Qin et al. · Carcinogenesis · 2006 · 60 citations

, , +16

Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1

Jessica Kalra, Brent W. Sutherland, Anna L. Stratford et al. · Oncogene · 2010 · 49 citations · Full text

1–5 of 11